OA11385A - Formulations comprising dissolved paroxetine. - Google Patents

Formulations comprising dissolved paroxetine. Download PDF

Info

Publication number
OA11385A
OA11385A OA1200000153A OA1200000153A OA11385A OA 11385 A OA11385 A OA 11385A OA 1200000153 A OA1200000153 A OA 1200000153A OA 1200000153 A OA1200000153 A OA 1200000153A OA 11385 A OA11385 A OA 11385A
Authority
OA
OAPI
Prior art keywords
paroxetine
solid
carrier
capsule
solid dosage
Prior art date
Application number
OA1200000153A
Other languages
English (en)
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of OA11385A publication Critical patent/OA11385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA1200000153A 1997-11-21 2000-05-19 Formulations comprising dissolved paroxetine. OA11385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation

Publications (1)

Publication Number Publication Date
OA11385A true OA11385A (en) 2004-01-27

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000153A OA11385A (en) 1997-11-21 2000-05-19 Formulations comprising dissolved paroxetine.

Country Status (24)

Country Link
EP (1) EP1033986A1 (tr)
JP (1) JP2001523718A (tr)
KR (1) KR20010032320A (tr)
CN (1) CN1279608A (tr)
AP (1) AP2000001821A0 (tr)
AR (1) AR015485A1 (tr)
AU (1) AU1168099A (tr)
BG (1) BG104527A (tr)
BR (1) BR9814220A (tr)
CO (1) CO4970832A1 (tr)
DZ (1) DZ2658A1 (tr)
EA (1) EA200000552A1 (tr)
GB (1) GB9724544D0 (tr)
HU (1) HUP0100580A3 (tr)
IL (1) IL136106A0 (tr)
MA (1) MA24704A1 (tr)
NO (1) NO20002590L (tr)
OA (1) OA11385A (tr)
PE (1) PE20000381A1 (tr)
PL (1) PL340555A1 (tr)
SK (1) SK7342000A3 (tr)
TR (1) TR200001423T2 (tr)
WO (1) WO1999026625A1 (tr)
ZA (1) ZA9810637B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
DE60004768T2 (de) 1999-07-01 2004-07-08 Italfarmaco S.P.A. Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
JP2005531495A (ja) * 2001-12-21 2005-10-20 シャイア ラボラトリーズ，インコーポレイテッド 高い物理的安定性を有する経口カプセル製剤
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
US20120322752A1 (en) * 2009-12-08 2012-12-20 Sung Kyun Lee SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
CN1249686A (zh) * 1997-01-15 2000-04-05 史密丝克莱恩比彻姆有限公司 帕罗西丁制剂

Also Published As

Publication number Publication date
EP1033986A1 (en) 2000-09-13
PE20000381A1 (es) 2000-05-07
BR9814220A (pt) 2001-12-26
ZA9810637B (en) 2000-05-22
AP2000001821A0 (en) 2000-06-30
AR015485A1 (es) 2001-05-02
MA24704A1 (fr) 1999-07-01
KR20010032320A (ko) 2001-04-16
CN1279608A (zh) 2001-01-10
WO1999026625A1 (en) 1999-06-03
HUP0100580A3 (en) 2002-05-28
GB9724544D0 (en) 1998-01-21
CO4970832A1 (es) 2000-11-07
NO20002590L (no) 2000-07-19
IL136106A0 (en) 2001-05-20
EA200000552A1 (ru) 2000-10-30
JP2001523718A (ja) 2001-11-27
TR200001423T2 (tr) 2000-10-23
PL340555A1 (en) 2001-02-12
SK7342000A3 (en) 2000-12-11
AU1168099A (en) 1999-06-15
NO20002590D0 (no) 2000-05-19
BG104527A (en) 2001-04-30
HUP0100580A2 (hu) 2002-04-29
DZ2658A1 (fr) 2003-03-22

Similar Documents

Publication Publication Date Title
US6524615B2 (en) Controlled release pharmaceutical composition
RU2278657C2 (ru) Предконцентрат микроэмульсии
US8293270B2 (en) Lipophilic vehicle-based dual controlled release matrix system
US6491950B1 (en) Controlled release pharmaceutical composition
CA2376217A1 (en) Novel formulations comprising lipid-regulating agents
JP2009197015A (ja) ハードシェルカプセル剤のためのイブプロフェン溶液
AU2019329905B2 (en) Vitamin D pediatric dosage forms, methods of making and using
OA11385A (en) Formulations comprising dissolved paroxetine.
EP1330244B1 (en) Compositions comprising modafinil compounds
US20020032220A1 (en) Formulations comprising dissolved paroxetine
AU2013213706A1 (en) An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
CA2310407A1 (en) Formulations comprising dissolved paroxetine
MXPA00005030A (en) Formulations comprising dissolved paroxetine
JP2003504392A (ja) 新規医薬製剤
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin
KR20020039354A (ko) 바소프레신 길항제 제형 및 방법
AU2002211677B2 (en) Compositions comprising modafinil compounds
EP2890369A1 (en) Pharmaceutical compositions comprising an active agent
AU2002211677A1 (en) Compositions comprising modafinil compounds